Skip to content

GyneFix-Viz*: A Study of Serosal-Anchor (SA) Distance

GYNEFIX-VIZ*: A STUDY OF SEROSAL-ANCHOR (SA) DISTANCE IN WOMEN IMMEDIATELY AND 6-8 WEEKS FOLLOWING INSERTION

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01979835
Acronym
GF
Enrollment
1030
Registered
2013-11-08
Start date
2013-02-28
Completion date
2020-03-03
Last updated
2020-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraception

Keywords

intrauterine device, contraception

Brief summary

The GyneFix-Viz is a frameless copper intrauterine device (IUD) used for contraception. The GyneFix IUD has been marketed in Europe and Asia for about 10 years. The new anchor in the GyneFix IUD was designed to be more visible on ultrasound and this could improve safety by reducing failed insertions and perforations. We now need to know how easy it is for doctors to see and measure the distance of the anchor to the outside of the uterus. The purpose of this open, prospective, observational study is to assess the feasibility of measuring the distance from the serosa of the uterus to the anchor following insertion of the GyneFix-Viz and at follow-up 6-8 weeks later. Secondary objectives are to assess the ease and pain of insertion, the acceptability of the device to Canadian women and any complications. We will also compare expulsion rates in post-abortion and other women.

Interventions

DEVICEGyneFix Viz

insertion of GyneFix Viz and measurment of the SA distance

Sponsors

Wiebe, Ellen, M.D.
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
16 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

1. healthy women requesting intrauterine contraception 2. willing to have a GyneFix IUD for pregnancy prevention 3. able to return for a follow-up ultrasound 4. able to read and understand consent form

Exclusion criteria

1. Any contraindications precluding insertion of an IUD (e.g., infection, cancer of the uterus, malformation etc.) 2. Immediately after a pregnancy interruption \> 10 weeks gestation

Design outcomes

Primary

MeasureTime frameDescription
Serosal-anchor Measurement6-8 weeksendovaginal ultrasound measurement of the distance from the anchor of the device and the serosal surface of the uterus

Secondary

MeasureTime frameDescription
Complications5 yearsNumber of participants with complications and removals at the end of the 5-year follow-up period

Countries

Canada

Participant flow

Participants by arm

ArmCount
Women Enrolled to Have GF Inserted
All women requesting a GF and eligible for insertion who signed the informed consent document.
1,030
Total1,030

Withdrawals & dropouts

PeriodReasonFG000
Follow-upLost to Follow-up32
Primary Outcome SA Measurmentfailed insertion18

Baseline characteristics

CharacteristicWomen Enrolled to Have GF Inserted
Age, Continuous28.7 years
STANDARD_DEVIATION 6
Region of Enrollment
Canada
1030 participants
Sex: Female, Male
Female
1030 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 1,012
other
Total, other adverse events
180 / 1,012
serious
Total, serious adverse events
9 / 1,012

Outcome results

Primary

Serosal-anchor Measurement

endovaginal ultrasound measurement of the distance from the anchor of the device and the serosal surface of the uterus

Time frame: 6-8 weeks

ArmMeasureValue (MEAN)Dispersion
Women Who Have a GyneFix Viz InsertedSerosal-anchor Measurement6.2 mmStandard Deviation 2.7
Secondary

Complications

Number of participants with complications and removals at the end of the 5-year follow-up period

Time frame: 5 years

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Women Who Have a GyneFix Viz InsertedComplicationsExplusion36 Participants
Women Who Have a GyneFix Viz InsertedComplicationsPerforation9 Participants
Women Who Have a GyneFix Viz InsertedComplicationsPregnancy11 Participants
Women Who Have a GyneFix Viz InsertedComplicationsRemoved to conceive97 Participants
Women Who Have a GyneFix Viz InsertedComplicationsRemoved because no longer needed19 Participants
Women Who Have a GyneFix Viz InsertedComplicationsRemoved because >5 years95 Participants
Women Who Have a GyneFix Viz InsertedComplicationsRemoved due to symptoms and other reasons150 Participants
Women Who Have a GyneFix Viz InsertedComplicationsRemoved, missing reason83 Participants
Women Who Have a GyneFix Viz InsertedComplicationsGyneFix in place420 Participants
Women Who Have a GyneFix Viz InsertedComplicationsMissing92 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026